Alkem Laboratories Limited has informed the Exchange regarding a press release dated August 05, 2020, titled "ALKEM launches Favipiravir in India under the brand name Alfluenza for the treatment of mild to moderate COVID-19.".
Press Release Aug 05 2020
Filed with NSE ·
6ix hasn’t read this filing yet.
Alkem Laboratories Ltd. on 6ix
In the deck
Later from Alkem Laboratories
- Press Release Oct 29 2020
- Press Release Jan 29 2021
- Press Release Mar 15 2021
- Press Release Mar 23 2021
- Press Release Jun 10 2021
Follow Alkem Laboratories into a list and get an email when it puts out news.
Follow Alkem Laboratories